Agilent (A) AI Stock Analysis

• Market Cap: $43.52B
• Dividend Yield: 0.68%
• Average Volume (3M): 1.75M
• Price to Earnings (P/E): 33.6
• Beta (1Y): 0.97
• Revenue Growth: 6.73%
• EPS Growth: 3.34%
• Country: US
• Employees: 17,900
• Sector: Technology
• Sector Strength: 88
• Industry: Medical - Diagnostics & Research
• EPS (TTM): 1.59
• Shares Outstanding: 283,500,430
• 10 Day Avg. Volume: 2,204,623
• 30 Day Avg. Volume: 1,749,042
• PEG Ratio: -1.46
• Price to Book (P/B): 6.14
• Price to Sales (P/S): 22.26
• P/FCF Ratio: 35.95
• Enterprise Value/Market Cap: 0.99
• Enterprise Value/Revenue: 6.21
• Enterprise Value/Gross Profit: 11.84
• Enterprise Value/Ebitda: 23.50
• 1Y Price Target: $167.92
• Price Target Upside: 9.39% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 12
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 75 Outperform
• Price Target: $172.00 ▲(12.05% Upside)

Agilent's strong financial performance and technical indicators are the most significant factors driving the score. The earnings call provided positive insights into future growth, despite some challenges. The high P/E ratio suggests caution regarding valuation.

Positive Factors

Revenue Growth

Agilent's ability to exceed revenue projections highlights its strong market position and effective demand capture, indicating potential for sustained growth.

Product Innovation

The introduction of new products like the Insight Series enhances Agilent's competitive edge and market diversification, supporting long-term growth.

Cost Management

Effective cost management through the Ignite model boosts operational efficiency, improving margins and financial resilience over time.

Negative Factors

Tariff and Margin Pressures

Ongoing tariff pressures could strain margins and profitability, posing a risk to Agilent's financial performance until mitigation strategies are fully realized.

US Market Challenges

Weakness in key US sectors may hinder Agilent's revenue growth, affecting its ability to capitalize on domestic market opportunities.

Environmental Forensics Market Decline

Declines in the environmental forensics market could limit Agilent's growth in this segment, impacting overall revenue diversification.

Agilent Business Overview & Revenue Model

Company Description

Agilent Technologies, Inc. (A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for laboratories worldwide. Its primary sectors include pharmaceutical, biotechnology, environmental, food, and chemical analysis. Core products encompass a wide range of analytical instruments such as mass spectrometers, chromatography systems, and molecular biology tools.

How the Company Makes Money

Agilent generates revenue through multiple key streams, primarily by selling its analytical instruments, software, and consumables to laboratories and research institutions across various sectors. The company also offers services such as instrument maintenance and support, which provide a steady stream of recurring revenue. Significant partnerships with research institutions and companies in the pharmaceutical industry further enhance its revenue potential by integrating Agilent's technologies into critical research and development processes. Additionally, Agilent's focus on innovation and new product development allows it to cater to emerging needs in the life sciences and chemical analysis markets, contributing to sustained revenue growth.

Agilent Financial Statement Overview

Summary

Agilent demonstrates strong profitability with a net profit margin of 23.32% and efficient cost management. However, a significant revenue decline of -72.58% is concerning, despite a stable balance sheet and positive free cash flow growth.

Income Statement

Agilent's income statement shows a significant decline in revenue for the latest period, with a revenue growth rate of -72.58%. Despite this, the company maintains a strong net profit margin of 23.32% and an EBITDA margin of 23.80%, indicating efficient cost management and profitability. However, the sharp revenue decline is a concern and impacts the overall score.

Balance Sheet

The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.50, indicating moderate leverage. The return on equity has been consistently strong, though it has slightly decreased over the years. The equity ratio is healthy, suggesting a solid capital structure. Overall, the balance sheet is robust, but the slight increase in debt levels should be monitored.

Cash Flow

Agilent's cash flow statement shows positive free cash flow growth of 11.20% in the latest period, indicating improved cash generation. The free cash flow to net income ratio is 1.0, suggesting efficient conversion of earnings into cash. However, the operating cash flow has decreased compared to previous years, which could impact future liquidity.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	6.95B	6.51B	6.83B	6.85B	6.32B
Gross Profit	3.64B	3.54B	3.46B	3.72B	3.41B
EBITDA	1.83B	1.87B	1.70B	1.91B	1.76B
Net Income	1.30B	1.29B	1.24B	1.25B	1.21B
Balance Sheet
Total Assets	12.73B	11.85B	10.76B	10.53B	10.71B
Cash, Cash Equivalents and Short-Term Investments	1.79B	1.33B	1.59B	1.05B	1.57B
Total Debt	3.35B	3.57B	2.73B	2.77B	2.73B
Total Liabilities	5.99B	5.95B	4.92B	5.23B	5.32B
Stockholders Equity	6.74B	5.90B	5.84B	5.30B	5.39B
Cash Flow
Free Cash Flow	1.15B	1.37B	1.47B	1.02B	1.30B
Operating Cash Flow	1.56B	1.75B	1.77B	1.31B	1.49B
Investing Cash Flow	-394.00M	-1.26B	-310.00M	-338.00M	-749.00M
Financing Cash Flow	-715.00M	-752.00M	-930.00M	-1.37B	-696.00M

Agilent Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 153.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For A, the sentiment is Positive. The current price of 153.5 is above the 20-day moving average (MA) of 148.34, above the 50-day MA of 141.80, and above the 200-day MA of 123.26, indicating a bullish trend. The MACD of 3.16 indicates Negative momentum. The RSI at 62.59 is Neutral, neither overbought nor oversold. The STOCH value of 73.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for A.

Agilent Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IQV	77 Outperform	$39.17B	31.58	19.55%	―	3.85%	-4.74%
DHR	75 Outperform	$160.19B	46.67	6.84%	0.54%	2.22%	-7.60%
A	75 Outperform	$43.52B	33.59	20.62%	0.68%	6.73%	3.34%
TMO	73 Outperform	$221.98B	34.14	13.14%	0.29%	3.22%	8.26%
WAT	70 Outperform	$24.02B	37.09	32.99%	―	6.90%	3.86%
MTD	66 Neutral	$29.65B	35.90	―	―	4.77%	7.93%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%

Agilent Corporate Events

Agilent CFO Resignation Announced, Interim Replacement Named

On July 11, 2025, Agilent Technologies announced the resignation of Robert W. McMahon, its Senior Vice President and Chief Financial Officer, effective July 31, 2025, due to personal reasons. Rodney Gonsalves, the current Vice President, Corporate Controller, and Principal Accounting Officer, will serve as interim CFO. Agilent remains confident in its long-term plans and expects its third-quarter financial results to align with previous guidance.